
Opinion|Videos|July 17, 2024
Vitiligo Treatment Strategies: Addressing Skin of Color Considerations, Long-Term Regimentation, and Disease Management
Author(s)Andrew F. Alexis, MD, MPH
Andrew Alexis, MD, MPH, presents the case of a 60-year-old man with a 5-year history of vitiligo who received topical ruxolitinib 1.5% cream and achieved gradual repigmentation over a six-month period.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- What is your impression of this case?
- What challenges does this case present with, if any?
- How do you decide when to consider transitioning to a different treatment vs continuing the current course?
- How would you approach the next steps of treatment for this patient?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5



















